|
Malignant neoplasm of urinary bladder
|
0.360 |
AlteredExpression
|
disease |
BEFREE |
In this study, we found that TUG1 was upregulated and microRNA-29c (miR-29c) was downregulated in BC tissues and cell lines.
|
29321088 |
2018 |
|
Bladder Neoplasm
|
0.360 |
AlteredExpression
|
disease |
BEFREE |
In this study, we found that TUG1 was upregulated and microRNA-29c (miR-29c) was downregulated in BC tissues and cell lines.
|
29321088 |
2018 |
|
Malignant neoplasm of urinary bladder
|
0.360 |
Biomarker
|
disease |
BEFREE |
Micro-RNA analyses of BC tissue revealed that miR-145 and miR-29c* function as tumor suppressors, whereas miR-183 and miR-17-5p function as oncogenic miRNAs.
|
26924873 |
2016 |
|
Bladder Neoplasm
|
0.360 |
Biomarker
|
disease |
BEFREE |
Micro-RNA analyses of BC tissue revealed that miR-145 and miR-29c* function as tumor suppressors, whereas miR-183 and miR-17-5p function as oncogenic miRNAs.
|
26924873 |
2016 |
|
Malignant neoplasm of urinary bladder
|
0.360 |
Biomarker
|
disease |
BEFREE |
To conclude, urine miR-210, miR-10b, and miR-29c are promising tumor markers for BC: bilharzial and nonbilharzial.
|
25620614 |
2015 |
|
Bladder Neoplasm
|
0.360 |
Biomarker
|
disease |
BEFREE |
To conclude, urine miR-210, miR-10b, and miR-29c are promising tumor markers for BC: bilharzial and nonbilharzial.
|
25620614 |
2015 |
|
Malignant neoplasm of urinary bladder
|
0.360 |
Biomarker
|
disease |
BEFREE |
An adenovirus containing microRNA-29c was used to infect the BIU-87 human bladder cancer cell line.
|
24870742 |
2014 |
|
Malignant neoplasm of urinary bladder
|
0.360 |
Biomarker
|
disease |
BEFREE |
Thus, miR-29c could be an active player in disease state of bladder cancer and it may be a promising tumor suppressor in bladder cancer.
|
24952510 |
2014 |
|
Bladder Neoplasm
|
0.360 |
Biomarker
|
disease |
BEFREE |
An adenovirus containing microRNA-29c was used to infect the BIU-87 human bladder cancer cell line.
|
24870742 |
2014 |
|
Bladder Neoplasm
|
0.360 |
Biomarker
|
disease |
BEFREE |
Thus, miR-29c could be an active player in disease state of bladder cancer and it may be a promising tumor suppressor in bladder cancer.
|
24952510 |
2014 |
|
Malignant neoplasm of urinary bladder
|
0.360 |
Biomarker
|
disease |
BEFREE |
Effect of miR-29b-1* and miR-29c knockdown on cell growth of the bladder cancer cell line T24.
|
24265332 |
2013 |
|
Bladder Neoplasm
|
0.360 |
Biomarker
|
disease |
BEFREE |
Effect of miR-29b-1* and miR-29c knockdown on cell growth of the bladder cancer cell line T24.
|
24265332 |
2013 |
|
Pulmonary Fibrosis
|
0.320 |
Biomarker
|
disease |
BEFREE |
These results indicated that miR-29c inhibited the development of silica-induced lung fibrosis.
|
29216763 |
2018 |
|
Pulmonary Fibrosis
|
0.320 |
Biomarker
|
disease |
BEFREE |
Taken together, miR-29c maintains epithelial integrity and promotes recovery from lung injury, thereby attenuating lung fibrosis in mice.
|
28799781 |
2017 |
|
Liver Cirrhosis
|
0.310 |
Biomarker
|
disease |
BEFREE |
ROC analysis revealed that hsa-miR-122-5p, hsa-miR-223 and hsa-miR-29c-3p identified patients with ≥F2 fibrosis with area under the curve (AUC) =0.745, 0.631 and 0.670, respectively. hsa-miR-122-5p identified patients with ≥F3 disease (AUC=0.783). hsa-miR-122-5p, hsa-miR-223 and hsa-miR-29c-3p identified patients with cirrhosis with AUC=0.776, 0.617 and 0.619, respectively.
|
30783469 |
2019 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Moreover, overexpression of miR-29c-3p inhibited tumor cell proliferation and colony formation, migration and invasion, and enhanced apoptosis and chemosensitivity to cisplatin.
|
31753063 |
2020 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Overexpression of miR-29c-3p significantly inhibited HCC cell proliferation, apoptosis, migration, and tumor growth in vivo.
|
30718452 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The potential of systemic miR-29c oligonucleotide-based therapy in overcoming 5-FU chemoresistance was evaluated in tumor xenograft model.
|
31037126 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In addition, we also identified that microRNA-29c-3p (a tumor suppressor) was significantly lower in the EC cells and linked to the low PTX sensitivity of EC.
|
30658067 |
2019 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The aim of the present study was to determine the functional effect of restoring miR-29c expression in endometrial cancer cell lines and to identify miR-29c targets involved in cancer progression. miR-29c expression in human endometrial tumour grades 1-3 and benign tissue as well as in the endometrial cancer cell lines Ishikawa, HEC1A and AN3CA were analysed using reverse transcriptase-quantitative PCR (RT-qPCR).
|
31404303 |
2019 |
|
Stomach Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The miR-29c-KIAA1199 axis regulates gastric cancer migration by binding with WBP11 and PTP4A3.
|
30626935 |
2019 |
|
Stomach Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Long non-coding RNA MYOSLID functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-29c-3p in gastric cancer.
|
31497917 |
2019 |
|
Stomach Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
To further determine the correlation between miR-29c and CDK6 in GC cell invasion and migration, the rescue experiments were performed by co-transfecting miR-29c inhibitor and CDK6 siRNA into AGS cells.
|
31599417 |
2019 |
|
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Taken together, the data of the present study demonstrated that TUG1 promoted proliferation and invasion and suppressed apoptosis in melanoma cells by regulating miR‑29c‑3p and its target gene, RGS1.
|
30720136 |
2019 |
|
Tumor Cell Invasion
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Additionally, functional assays showed that the miR-29c over-expression suppressed the invasion and migration capacities of GC cells.
|
31599417 |
2019 |